Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of anti-cancer drugs. The company is focused on the clinical development and commercialization of the next generation of monoclonal antibody-based therapeutics to treat cancer.
This information is reserved for PitchBook Platform users. To explore Valor Biotherapeutics‘s full profile, request access.
1 Former Executive
1 Former Board Member
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.